Title of the Deal: Death Note: The Musical
Category: Broadway & Theatrical Production
Number of Pages: 28 Pages
Investor Eligibility: Accredited Investors
Bringing a global phenomenon to the London stage, this production marks the English-language debut of one of history’s most successful manga franchises. By combining a proven, multi-platform intellectual property with a world-class production team at the Barbican Theatre, this offering captures a rare market window. The business model is strategically built as a “mothership” launchpad, designed to evolve from a limited-run residency into a long-term global franchise, including planned West End and Broadway transfers.
$249.00
Analyze the Business of Theatrical Franchise Scaling.
This comprehensive investment memo serves as your “Access Pass” to the mechanics behind the curtain. We strip away the glamour to provide rigorous, institutional-grade due diligence on a production that has already broken historical pre-sale records at the Barbican.
Franchise Economics: How to transition from a single-city production to a global royalty-bearing asset.
The “Founder Investor” Edge: Analysis of the unique pro-rata participation rights in future North American and international runs.
Structural Risk Mitigation: Deep dive into UK Theatre Tax Relief (TTR) and its impact on your net capital at risk.
IP Provenance: Validating the crossover potential of a 100M+ copy manga franchise into mainstream theatre.
Performance Benchmarking: Comparative analysis of recent Barbican blockbusters and their ROI trajectories.
The RUES Scoring Card: A proprietary framework evaluating the production’s Revenue Visibility, Unique IP, Execution Team, and Structure.
